Monitor participants closely : Regularly check blood glucose, blood pressure, liver enzymes, and electrolytes
A brilliant confidence booster during the regrowth journey
Tirzepatide (Mounjaro) Tirzepatide is unique because it targets two hormones: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
Individuals who should avoid or exercise extreme caution include: Immunocompromised patients : Those with primary immunodeficiency disorders, HIV/AIDS with low CD4 counts, active chemotherapy recipients, or individuals taking immunosuppressive medications (corticosteroids, biologics, transplant drugs) face increased infection risk Critically ill or hospitalized patients : Severely ill individuals, particularly those in intensive care settings or with compromised gut barrier function, should not receive probiotics outside controlled clinical protocols Patients with central venous catheters : Indwelling lines provide potential routes for bacterial translocation into the bloodstream Premature infants : The FDA issued a safety warning in October 2023 against using probiotics in preterm infants due to risk of invasive infection Patients with severe acute pancreatitis : Clinical guidelines from the American College of Gastroenterology recommend against probiotic use in this condition due to potential harm [15] [16] Additional populations requiring medical consultation: Pregnant and breastfeeding women should consult healthcare providers before using GLP-1 probiotics, as safety data in these populations remains limited
1, Table 1, Extended Data Tables 1 and 2, and Supplementary Section 4) and substance-use disorders (via modulation of dopaminergic pathways of reward, impulse control and decision-making
